AveXis

Biotech

Novartis dumps Rett gene therapy caught up in Zolgensma scandal

The action follows Novartis’ decision to gather extra data on the candidate in response to data manipulation during development of Zolgensma.
Nick Paul Taylor Oct 26, 2021 7:18am

Affinia prepares for clinic with $110M financing

May 3, 2021 10:10am

Lilly backs Jaguar Gene Therapy in $139M series B

Apr 13, 2021 8:15am

Deerfield unveils gene therapy play with 4 preclinical programs

Feb 25, 2021 7:00am

Taysha debuts with $30M, 15 gene therapy programs

Apr 29, 2020 8:00am

Garraway will take over as Roche's next CMO—Chutes & Ladders

Aug 23, 2019 9:30am